News Articles Tagged: FLT3 Inhibitors

FLT3 Inhibitors in AML: The Expanding Role of Targeted Therapies

An overview of FLT3 inhibitors, including Quizartinib, and their increasing importance in the targeted treatment of Acute Myeloid Leukemia (AML), especially for patients with specific mutations.

The Mechanism of Action: How Quizartinib Targets FLT3 in AML

Delve into the scientific details of Quizartinib's (AC220) mechanism of action, explaining its selective inhibition of FLT3 mutations in Acute Myeloid Leukemia (AML) and its impact on cancer cell survival.